More research investment needed to beat ALS
An effective treatment for ALS is becoming much more about 'when' than 'if.' The 'when' will ultimately depend on the financial support to pursue recent breakthroughs.

MARKHAM, ONT.—It is with great sadness that we said goodbye this month to Mauril Bélanger, MP for Ottawa-Vanier, Ont.. In the short time he lived with amyotrophic lateral sclerosis (ALS), Mr. Bélanger raised significant awareness about the harsh realities of this devastating neurodegenerative d...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy












